124 related articles for article (PubMed ID: 38582961)
1. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression.
Santhanam M; Kumar Pandey S; Shteinfer-Kuzmine A; Paul A; Abusiam N; Zalk R; Shoshan-Barmatz V
Mol Ther; 2024 Jun; 32(6):1934-1955. PubMed ID: 38582961
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro studies on the role of regulating Smac expression in the occurrence and development of colon cancer.
Zhang D; Yang N
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):206-210. PubMed ID: 38836659
[TBL] [Abstract][Full Text] [Related]
3. A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis.
Paul A; Krelin Y; Arif T; Jeger R; Shoshan-Barmatz V
Mol Ther; 2018 Mar; 26(3):680-694. PubMed ID: 29396267
[TBL] [Abstract][Full Text] [Related]
4. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K
Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mitochondrial Smac/DIABLO-selective release by survivin.
Ceballos-Cancino G; Espinosa M; Maldonado V; Melendez-Zajgla J
Oncogene; 2007 Nov; 26(54):7569-75. PubMed ID: 17546047
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer.
Hagenbuchner J; Oberacher H; Arnhard K; Kiechl-Kohlendorfer U; Ausserlechner MJ
Theranostics; 2019; 9(17):4909-4922. PubMed ID: 31410190
[TBL] [Abstract][Full Text] [Related]
7. SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis.
Pandey SK; Paul A; Shteinfer-Kuzmine A; Zalk R; Bunz U; Shoshan-Barmatz V
Mol Oncol; 2021 Nov; 15(11):3037-3061. PubMed ID: 33794068
[TBL] [Abstract][Full Text] [Related]
8. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis.
McNeish IA; Lopes R; Bell SJ; McKay TR; Fernandez M; Lockley M; Wheatley SP; Lemoine NR
Exp Cell Res; 2005 Jan; 302(1):69-82. PubMed ID: 15541727
[TBL] [Abstract][Full Text] [Related]
9. [Effect of antisurvivin oligodeoxynucleotides on proliferation and apoptosis in gastric cancer cell line BGC-823 and the molecular mechanism].
Li Y; Fan LQ; Sun Y; Zhao Q; Tan BB; Liu Y
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):265-9. PubMed ID: 21575496
[TBL] [Abstract][Full Text] [Related]
10. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
11. Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.
Song Z; Yao X; Wu M
J Biol Chem; 2003 Jun; 278(25):23130-40. PubMed ID: 12660240
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for recognition of H3T3ph and Smac/DIABLO N-terminal peptides by human Survivin.
Du J; Kelly AE; Funabiki H; Patel DJ
Structure; 2012 Jan; 20(1):185-95. PubMed ID: 22244766
[TBL] [Abstract][Full Text] [Related]
14. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
15. Nuclear interaction of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells.
Kim JY; Chung JY; Lee SG; Kim YJ; Park JE; Yoo KS; Yoo YH; Park YC; Kim BG; Kim JM
Biochem Biophys Res Commun; 2006 Dec; 350(4):949-54. PubMed ID: 17045968
[TBL] [Abstract][Full Text] [Related]
16. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
Fandy TE; Shankar S; Srivastava RK
Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
[TBL] [Abstract][Full Text] [Related]
17. The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells.
Lin IL; Lin YT; Chang YC; Kondapuram SK; Lin KH; Chen PC; Kuo CY; Coumar MS; Cheung CHA
Toxicol Appl Pharmacol; 2024 Apr; 485():116888. PubMed ID: 38452945
[TBL] [Abstract][Full Text] [Related]
18. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P
Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design, synthesis and anticancer effect of cyclic Smac-polyarginine peptides.
Khalily MP; Gerekçi S; Güleç EA; Özen C; Özçubukçu S
Amino Acids; 2018 Nov; 50(11):1607-1616. PubMed ID: 30123940
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
